EMPA-REG DOSE Trademark

Trademark Overview

On Tuesday, September 17, 2013, a trademark application was filed for EMPA-REG DOSE with the United States Patent and Trademark Office. The USPTO has given the EMPA-REG DOSE trademark a serial number of 79138320. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Saturday, September 16, 2023. This trademark is owned by Boehringer Ingelheim International GmbH. The EMPA-REG DOSE trademark is filed in the Education & Entertainment Services category with the following description:

Publication of printed matter with the results of clinical studies involving pharmaceutical preparations and publication of electronic publications with the results of clinical studies involving pharmaceutical preparations
empa-reg dose

General Information

Serial Number79138320
Word MarkEMPA-REG DOSE
Filing DateTuesday, September 17, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSaturday, September 16, 2023
Registration Number4626734
Registration DateTuesday, October 28, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 12, 2014

Trademark Statements

Goods and ServicesPublication of printed matter with the results of clinical studies involving pharmaceutical preparations and publication of electronic publications with the results of clinical studies involving pharmaceutical preparations

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 14, 2021
Primary Code041
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Friday, November 15, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 19, 2013APPLICATION FILING RECEIPT MAILED
Tuesday, December 10, 2013ASSIGNED TO EXAMINER
Tuesday, December 31, 2013REFUSAL PROCESSED BY IB
Thursday, November 14, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, December 11, 2013NON-FINAL ACTION WRITTEN
Thursday, December 12, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, December 12, 2013REFUSAL PROCESSED BY MPU
Thursday, December 12, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, June 26, 2014ASSIGNED TO LIE
Wednesday, July 23, 2014NOTICE OF PUBLICATION
Wednesday, July 23, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, June 12, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 16, 2014PAPER RECEIVED
Thursday, July 3, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 3, 2014AMENDMENT FROM APPLICANT ENTERED
Monday, July 7, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 10, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 23, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Friday, August 8, 2014NOTIFICATION PROCESSED BY IB
Tuesday, August 12, 2014PUBLISHED FOR OPPOSITION
Wednesday, January 28, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, March 23, 2015FINAL DISPOSITION PROCESSED
Monday, March 23, 2015FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, October 28, 2014REGISTERED-PRINCIPAL REGISTER
Friday, April 10, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, May 14, 2021CANCELLED SECTION 71
Friday, January 14, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, May 12, 2022INVALIDATION PROCESSED
Thursday, May 12, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sunday, April 14, 2024DEATH OF INTERNATIONAL REGISTRATION
Sunday, April 14, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Monday, July 11, 2022TOTAL INVALIDATION PROCESSED BY THE IB

Related Keywords

dose empa involving pharmaceutical preparations publication studies clinical results publications electronic matter